Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
Natera(NTRA) stock is priced at $269.95, giving the company a market capitalization of 38.62B. It carries a P/E multiple of -164.47.
As of 2026-07-11, Natera(NTRA) stock has fluctuated between $268.97 and $283.87. The current price stands at $269.95, placing the stock +0.4% above today's low and -4.9% off the high.
The Natera(NTRA)'s current trading volume is 960.53K, compared to an average daily volume of 1.71M.
During the past year, Natera(NTRA) stock moved between $131.81 at its lowest and $288.04 at its peak.
During the past year, Natera(NTRA) stock moved between $131.81 at its lowest and $288.04 at its peak.
NTRA News
Natera (NTRA) is back in focus after securing Class C certification under the European Union’s In Vitro Diagnostic Regulation for its Signatera cancer test, a r...
Natera recently reported that Monica Bertagnolli resigned from its board due to her new role at the National Academy of Medicine and highlighted fresh JAMA Onco...
Morgan Stanley raised the firm’s price target on Natera (NTRA) to $310 from $250 and keeps an Overweight rating on the shares. The firm is updating its model ah...
Analyst ratings
88%
of 24 ratingsMore NTRA News
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
Natera (NTRA) announced the publication of new data in JAMA Oncology, evaluating the utility of Signatera, its personalized molecular residual disease test, in...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.